Net debt/EBITDA společnosti InVivo Therapeutics Corp
Jaká je hodnota metriky Net debt/EBITDA společnosti InVivo Therapeutics Corp?
Hodnota metriky Net debt/EBITDA společnosti InVivo Therapeutics Holdings Corp je 2.57
Jaká je definice metriky Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností InVivo Therapeutics Corp
Čemu se věnuje společnost InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Firmy s metrikou net debt/ebitda podobnou společnosti InVivo Therapeutics Corp
- Hodnota metriky Net debt/EBITDA společnosti Ayala Pharmaceuticals je 2.56
- Hodnota metriky Net debt/EBITDA společnosti Egdon Resources plc je 2.56
- Hodnota metriky Net debt/EBITDA společnosti Helmerich & Payne je 2.56
- Hodnota metriky Net debt/EBITDA společnosti ABB Ltd je 2.57
- Hodnota metriky Net debt/EBITDA společnosti Bel Fuse je 2.57
- Hodnota metriky Net debt/EBITDA společnosti Podium Minerals je 2.57
- Hodnota metriky Net debt/EBITDA společnosti InVivo Therapeutics Corp je 2.57
- Hodnota metriky Net debt/EBITDA společnosti Cue Biopharma Inc je 2.57
- Hodnota metriky Net debt/EBITDA společnosti Emerald Resources NL je 2.57
- Hodnota metriky Net debt/EBITDA společnosti Accell NV je 2.57
- Hodnota metriky Net debt/EBITDA společnosti Accell N.V je 2.57
- Hodnota metriky Net debt/EBITDA společnosti Pci Pal Plc je 2.58
- Hodnota metriky Net debt/EBITDA společnosti Auryn Resources je 2.58